CSBR - Company ID 0000771856
The table below shows CHAMPIONS ONCOLOGY, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $59.42M | $56.94M | $50.16M | $53.87M | $49.11M | $41.04M |
| Cost of revenue | $30.90M | $28.39M | $29.40M | $29.53M | $23.63M | $21.45M |
| Gross profit | - | - | - | - | - | - |
| R&D | $9.08M | $6.83M | $9.54M | $11.54M | $9.37M | $7.20M |
| SG&A |
CHAMPIONS ONCOLOGY, INC. reported annual revenue of $59.42M for fiscal year 2026. That is up 4.4% from $56.94M in fiscal 2025. Over the 9 fiscal years shown, annual revenue grew from $20.24M (FY 2018) to $59.42M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $11.15M |
| $9.34M |
| $11.07M |
| $10.24M |
| $9.12M |
| $6.51M |
| Operating income | -$1.14M | $4.55M | -$7.36M | -$5.26M | $607.00K | $366.00K |
| Income tax | $246.00K | -$75.00K | -$32.00K | $68.00K | $35.00K | $75.00K |
| Net income | -$1.18K | $4.70M | -$7.28M | -$5.33M | $548.00K | $362.00K |
| EPS (diluted) | -$0.08 | $0.33 | -$0.54 | -$0.39 | $0.04 | $0.02 |